RCT | Efficacy of drug-eluting stent vs. bare metal stent for symptomatic femoropopliteal peripheral artery disease.
7 Nov, 2022 | 12:29h | UTCEfficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial – Circulation (free for a limited period)
Commentary on Twitter
#OriginalResearch: #EMINENT RCT- DES superior to BMS in 1 year patency rates for symptomatic femoropopliteal arterial disease @espogiov @K_Stavroulakis @YannGoueffic #AHAJournals https://t.co/cdt4Te2TZx pic.twitter.com/qDGvKvtNYd
— Circulation (@CircAHA) October 25, 2022